One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Immediate-release gabapentin only. Do not apply this table to Horizant or Gralise. Source summary and reproduced table use different boundary notation.
Immediate-release gabapentin, GRALISE and HORIZANT are not interchangeable renal protocols. HORIZANT also has indication-specific schedules.
What to reconcile: Select the actual formulation and indication before using a dose or dialysis instruction.
Open this note and its source referencesThe RX table prints greater-than-30 to 59 and greater-than-15 to 29 bands; dialysis supplements are paired to maintenance regimens.
What to reconcile: Confirm the exact boundary and matched supplement in the complete current product table; no automatic dose calculation is provided.
Open this note and its source referencesThe RX table prints >30 to 59 and >15 to 29; exactly 30 is not clearly assigned. The hemodialysis supplement also belongs with a selected maintenance regimen.
What to reconcile: Verify the current table rather than silently rounding into a band. Do not select a supplement without its corresponding maintenance context.
Open this note and its source referencesAt GFR 30-60 and 15-30 mL/min the handbook advises starting low and titrating to response. Below 15 it lists 300 mg on alternate days or 100 mg nightly initially. For neuropathic pain or restless legs in moderate/severe impairment it separately suggests starting 100 mg daily; it advises no loading dose for neuropathic pain in renal patients.
gabapentin:rdh5-471-1 · Source locator: Renal impairment; Other information
For HD/high-flux treatment it describes a 300-400 mg load in previously untreated patients, then 200-300 mg after each HD session, titrated to tolerability. The neuropathic-pain no-load exception still applies. APD/CAPD follows the <15 band; continuous therapy follows the 15-30 band.
gabapentin:rdh5-471-2 · Source locator: Renal replacement; Other information
The handbook HD-only approach and the label maintenance-plus-supplement approach are distinct. Do not add their doses together. The book's general gabapentin recommendations do not establish dosing for GRALISE or the enacarbil prodrug.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=gabapentin&s1=rdh5-471&h1=16427eb122e65ee0d26d735f1a3d681674e45c73df027867859f6eabb913e143